Cevimeline Hydrochloride Capsule
Product Images NDC 70771-1982

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Cevimeline Hydrochloride (NDC 70771-1982). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (7e885fcf 536e 4d43 94c8 2941e9e9a7a2 01)

Image (7e885fcf 536e 4d43 94c8 2941e9e9a7a2 01)
The text provides information about Cevimeline Hydrochloride Capsules, each containing 30 mg of Cevimeline Hydrochloride USP. It gives directions for usage and storage, including keeping the medication in a child-resistant container at controlled room temperature. The medication is manufactured by Zydus Pharmaceuticals Ltd in India. Always refer to the package insert for complete prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.